Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01938547 · ClinicalTrials.gov registry record · Phase 4
Assessment of Efficacy, Safety and Dosing of Clevidipine in Pediatric Participants Undergoing Surgery (PIONEER)
A Phase 4 study, sponsored by Chiesi Farmaceutici S.p.A..
- Terminated
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
NCT01938547 is a Phase 4 study that was terminated before completion, run by Chiesi Farmaceutici S.p.A.. The registered enrollment target is 22 participants.
The verdict
NCT01938547, a Phase 4 study, was terminated before completion, sponsored by Chiesi Farmaceutici S.p.A..
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
Study Summary
Evaluate the efficacy, safety, and dosing of clevidipine as an intravenous (IV) infusion for blood pressure (BP) management in paediatric participants in the perioperative setting.
Interventions
- DRUG clevidipine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2014-03-17 |
| Est. Completion | 2024-02-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01938547
The ClinicalTrials.gov registry entry for NCT01938547 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Chiesi Farmaceutici S.p.A., which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which clevidipine is the first listed.
NCT01938547 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01938547 about?
NCT01938547 is a clinical study titled "Assessment of Efficacy, Safety and Dosing of Clevidipine in Pediatric Participants Undergoing Surgery (PIONEER)". Evaluate the efficacy, safety, and dosing of clevidipine as an intravenous (IV) infusion for blood pressure (BP) management in paediatric participants in the perioperative setting.
What is the current status of trial NCT01938547?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2014-03-17. Estimated completion is 2024-02-20.
What interventions are being tested in trial NCT01938547?
The interventions under investigation include: clevidipine (DRUG).
Who is sponsoring clinical trial NCT01938547?
This trial is sponsored by Chiesi Farmaceutici S.p.A., which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.